Fundación Jiménez Díaz
Madrid 28040
7 studies enrolling now · 33 studies all time
What they study most
ADPKD, Acute Respiratory Failure, Adenocarcinoma of the Lung, Advanced Solid Tumors, Arthritis, Rheumatoid, Autosomal Dominant Polycystic Kidney, Biliary Tract Cancer, Bladder Cancer, Breast Cancer, Breast Neoplasms, Chronic Kidney Disease, Chronic Migraine, Headache
Studies at this site
- Beamion BCGC-1: A Study to Find a Suitable Dose of Zongertinib Used Alone and in Combination With Other Treatments to Test Whether it Helps People With Different Types of HER2+ Cancer That Has Spread — Recruiting now
- DAREON ® -Lung-1: A Study in People With Advanced Small Cell Lung Cancer to Compare Obrixtamig Plus Atezolizumab, Carboplatin, and Etoposide Treatment With Standard Chemotherapy — Recruiting now
- A Study to Test Whether Nerandomilast Helps People With Lungfibrosis Related to Rheumatic Diseases — Recruiting now
- Beamion LUNG-3: Adjuvant Zongertinib vs Standard Treatment in People With Completely Resected Stage II-IIIB NSCLC Harboring Activating HER2 TKD Mutations — Recruiting now
- A Study of OTP-01, a Dual Paratopic PD-1/VEGFR2 Antibody, in Patients With Advanced Solid Tumors — Recruiting now
- Real-world Prospective Study on the Use of Anti-CGRP Drugs in Migraine — Recruiting now
- Enroll -HD: A Prospective Registry Study in a Global Huntington's Disease Cohort — Recruiting now
- A Study to Test Different Doses of BI 1831169 Alone and in Combination With an Anti-PD-1 Antibody in People With Different Types of Advanced Cancer (Solid Tumors) — Paused
- A Study to Test Long-term Treatment With Brigimadlin in People With Solid Tumours Who Took Part in a Previous Study With This Medicine — Running, not enrolling
- Brightline-2: A Study to Test Whether Brigimadlin (BI 907828) Helps People With Cancer in the Biliary Tract, Pancreas, Lung or Bladder — Completed
- DAREONᵀᴹ-8: A Study to Test How Well Different Doses of BI 764532 in Addition to Standard of Care Are Tolerated by People With Advanced Small Cell Lung Cancer — Running, not enrolling
- PALbociclib CoLlaborative Adjuvant Study — Running, not enrolling
- This Study Aims to Find the Best Dose of BI 907828 (Brigimadlin) in Patients With Different Types of Advanced Cancer (Solid Tumors) — Completed
- Brightline-1: A Study to Compare Brigimadlin (BI 907828) With Doxorubicin in People With a Type of Cancer Called Dedifferentiated Liposarcoma — Completed
- SyncAV Post-Market Trial — Running, not enrolling
- Dose Finding, Efficacy and Safety of BI 655064 in Patients With Active Lupus Nephritis — Completed
- 177Lu-PSMA-I&T for Metastatic Castration-Resistant Prostate Cancer — Running, not enrolling
- This Study in Patients With Different Types of Cancer (Solid Tumours) Aims to Find a Safe Dose of Xentuzumab in Combination With Abemaciclib With or Without Hormonal Therapies. The Study Also Tests How Effective These Medicines Are in Patients With Lung and Breast Cancer — Completed
- Apixaban for the Treatment of Venous Thromboembolism in Patients With Cancer — Completed
- A Trial of Bardoxolone Methyl in Patients With ADPKD - FALCON — Stopped early
- Colchicine Coronavirus SARS-CoV2 Trial (COLCORONA) — Stopped early
- A Study to Test Whether Different Doses of BI 690517 Alone or in Combination With Empagliflozin Improve Kidney Function in People With Chronic Kidney Disease — Completed
- A Study to Test the Effect of Different Doses of Avenciguat (BI 685509) on Kidney Function in People With Chronic Kidney Disease — Completed
- Effect of Nintedanib on Biomarkers of Extracellular Matrix Turnover in Patients With Idiopathic Pulmonary Fibrosis and Limited Forced Vital Capacity Impairment — Completed
- MOre REsponse on Cardiac Resynchronization Therapy With MultiPoint Pacing — Stopped early
- Controlled Study of Rigosertib Versus Physician's Choice of Treatment in MDS Patients After Failure of an HMA — Stopped early
- Clinical Trial of BI 425809 Effect on Cognition and Functional Capacity in Schizophrenia — Completed
- A Safety and Efficacy Study of Farletuzumab in Participants With Adenocarcinoma of the Lung — Completed
- Cardiovascular and Renal Microvascular Outcome Study With Linagliptin in Patients With Type 2 Diabetes Mellitus (CARMELINA) — Completed
- Third International Study on Mechanical Ventilation — Completed
- BI 695501 Compared to Adalimumab in Patients With Active Rheumatoid Arthritis — Completed
- Study of the AeriSeal System for HyPerInflation Reduction in Emphysema (ASPIRE) — Stopped early
- EASE Trial: Exhale Airway Stents for Emphysema — Status unconfirmed